Table 3.
PRSice-2 polygenic risk score (PRS) prediction results for UK Biobank target samples, for optimal p value threshold.
| Measure pair | Target sample | Threshold | PRS R2 | Full R2 | Null R2 | Coefficient | Standard error | p | No. of SNP | Empirical p |
|---|---|---|---|---|---|---|---|---|---|---|
| HAID–HAID | AA | 0.36 | 0.0104 | 0.0248 | 0.0144 | 112,697 | 40,950.5 | 0.0059 | 132,397 | 0.0701 |
| HAID–HD | AA | 0.017 | 0.0033 | 0.0991 | 0.0958 | −7664.44 | 2951.83 | 0.0094 | 11,338 | 1 |
| HD–HAID | AA | 0.016 | 0.0015 | 0.0159 | 0.0144 | 4257.94 | 4092.96 | 0.2982 | 15,955 | 1 |
| HD–HD | AA | 0.019 | 0.0006 | 0.0964 | 0.0958 | −2025.13 | 1827.21 | 0.2677 | 17,932 | 1 |
| HAID–HAID | CH | 0.14005 | 0.0041 | 0.0212 | 0.0172 | 31,395.8 | 27,561.6 | 0.2547 | 42,704 | 1 |
| HAID–HD | CH | 0.0003 | 0.0025 | 0.0687 | 0.0662 | −730.731 | 569.454 | 0.1994 | 317 | 1 |
| HD–HAID | CH | 0.0091 | 0.0210 | 0.0382 | 0.0172 | 10,772.2 | 4188.19 | 0.0101 | 7853 | 0.1025 |
| HD–HD | CH | 0.015 | 0.0095 | 0.0757 | 0.0662 | 5924.37 | 2355.89 | 0.0119 | 11,034 | 0.1085 |
| HAID–HAID | EA | 0.0092 | 0.0017 | 0.0701 | 0.0684 | 15,670.8 | 3775.81 | 3.320E−05 | 10,648 | 0.0009 |
| HAID–HD | EA | 0.35 | 0.0013 | 0.0468 | 0.0455 | 53,336.3 | 10,047.5 | 1.106E−07 | 183,790 | <0.0001 |
| HD–HAID | EA | 0.019 | 0.0027 | 0.0711 | 0.0684 | 13207 | 2506.83 | 1.376E−07 | 24,107 | <0.0001 |
| HD–HD | EA | 0.018 | 0.0124 | 0.0579 | 0.0455 | 18,389.9 | 1111.69 | 1.821E−61 | 23,187 | <0.0001 |
| HAID–HAID | SA | 0.045 | 0.0032 | 0.0424 | 0.0392 | −19,437.9 | 7590.78 | 0.0104 | 28,737 | 1 |
| HAID–HD | SA | 0.1 | 0.0007 | 0.0457 | 0.0450 | −9085.58 | 5864.3 | 0.1213 | 55,832 | 1 |
| HD–HAID | SA | 0.0037 | 0.0014 | 0.0407 | 0.0392 | −2137.48 | 1241.07 | 0.0850 | 5932 | 1 |
| HD–HD | SA | 0.28005 | 0.0075 | 0.0525 | 0.0450 | 24,413.7 | 4746.59 | 2.698E−07 | 123,566 | <0.0001 |
Measure pair denotes base sample polygenic risk scores constructed from UK Biobank genome-wide association study on British samples of either wearing a hearing aid (HAID) or having hearing difficulties (HD), respectively, predicting the UK Biobank target phenotypes HAID and HD, respectively. Target sample refers to the four UK Biobank subpopulations, African (AA), Chinese (CH), European (EA), and South Asian (SA), described in the text. Threshold is the p value threshold for SNP inclusion that maximised variance explained in the respective target phenotype. PRS R2 is the variance in the target phenotype explained by the PRS. Full R2 is the variance explained by the full-model regression, which includes the PRS as well as the covariates age and sex, while Null R2 does not include the PRS, just the covariates. Coefficient is the regression coefficient for the PRS term, with standard error and p its corresponding standard error and p value. No. of SNP is the number of SNPs included in the PRS and empirical p is the p value obtained from simulation, which corrects for both multiple thresholds tested in order to obtain the optimal threshold and for relatedness in the sample, such as the inclusion of DZ twin pairs.